Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Du

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcomeTiantian Sun, Wan Du, Hua Xiong, et al.
Nature Cell Biology|May 7, 2021
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapyGaopeng Li, Ilona Kryczek, Jutaek Nam, et al.
Nature Immunology|March 26, 2021
The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunityJiajia Zhou, Ilona Kryczek, Shasha Li, et al.
Cancer Discovery|February 25, 2021
Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and DegradationWan Du, Fang Hua, Xiong Li, et al.
Nature Communications|August 15, 2023
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoYong Tao, Veronica Lamas, Wan Du, et al.
Oncogene|October 24, 2019
A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90Chen-Yang Yu, Ji-Xuan Han, Junfang Zhang, et al.
The Journal of Pathology|February 21, 2013
Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancerYan-Wei Lin, Lin-Lin Ren, Hua Xiong, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2014
TMEFF2 deregulation contributes to gastric carcinogenesis and indicates poor survival outcomeTiantian Sun, Wan Du, Hua Xiong, et al.
Nature Cell Biology|May 7, 2021
LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapyGaopeng Li, Ilona Kryczek, Jutaek Nam, et al.
Nature Immunology|March 26, 2021
The ubiquitin ligase MDM2 sustains STAT5 stability to control T cell-mediated antitumor immunityJiajia Zhou, Ilona Kryczek, Shasha Li, et al.
Cancer Discovery|February 25, 2021
Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and DegradationWan Du, Fang Hua, Xiong Li, et al.
Nature Communications|August 15, 2023
Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoYong Tao, Veronica Lamas, Wan Du, et al.
Oncogene|October 24, 2019
A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90Chen-Yang Yu, Ji-Xuan Han, Junfang Zhang, et al.
The Journal of Pathology|February 21, 2013
Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancerYan-Wei Lin, Lin-Lin Ren, Hua Xiong, et al.
Pageof 6